Company / Total Assets
Sana Biotechnology, Inc. Total Assets History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$501.0M
FY2024
5-year range
$501.0M / $1.1B
FY2020-FY2024
Trend
-11.4%
vs FY2023
Sector context
#142 of 214
Health Care
What the data says
At $501M, Sana Biotechnology, Inc.'s total assets ranks #142 of 214 in the Health Care sector. Total Assets has declined for 3 consecutive years, from $1.1B in FY2021 to $501M in FY2024.
Based on SEC 10-K filings.
$501M in FY2024 with a 3-year CAGR of -23.7%.
Declined from $823M to $501M over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- -23.7%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#142 of 214 in Health CareTop 66% of 214This company $501.0M Sector average $7.5B
▼
-93.3% below sector average
Key checks
Key Insights
- Sana Biotechnology, Inc.'s total assets has declined for 3 consecutive years.
- 3-year CAGR of -23.7%, indicating a declining trend.
- In FY2024, total assets decreased 11.4% year-over-year.
- Ranks #142 out of 214 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.11 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $501.0M | -11.4% |
| FY2023 | $565.3M | -31.3% |
| FY2022 | $822.7M | -27.2% |
| FY2021 | $1.1B | +54.7% |
| FY2020 | $730.3M | - |
| FY2019 | - | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026